Protein expression of c-erbB-2 and p53 in normal ducts, ductal carcinoma in situ and invasive carcinoma of the same breast

Menezes, Marcus Vinicius Martins de; Cestari, Anna Letícia Oliveira; Almeida, Orlando; Alvarenga, Marcelo; Pinto, Glauce Aparecida; Gurgel, Maria Salete Costa; Souza, Gustavo Antônio de; Zeferino, Luiz Carlos.
São Paulo med. j ; 124(3): 121-124, May-June. 2006. tab
Artigo em Inglês, Português | LILACS | ID: lil-435889

Documentos relacionados

  1. Accounting for Preinvasive Conditions in Analysis of Invasive Cancer Risk: Application to Breast Cancer.
  2. The Landmark Series-Ductal Carcinoma in Situ: The Evolution of Treatment.
  3. Atypical cystic hypersecretory lesions of the breast commonly harbour TP53 alterations.
  4. Ductal Carcinoma in Situ: State-of-the-Art Review.
  5. Preoperative diagnosis of ductal carcinoma in situ of the breast over a 24-year period.
  6. Upgrade Rates of Variant Lobular Carcinoma In Situ Compared to Classic Lobular Carcinoma In Situ Diagnosed in Core Needle Biopsies: A 10-Year Single Institution Retrospective Study.
  7. Accuracy of the Breast Cancer Surveillance Consortium Model Among Women with LCIS.
  8. Ductal carcinoma in situ with and without microinvasion: is there a clinically meaningful difference in outcome?
  9. Canine and feline in situ mammary carcinoma: A comparative review.
  10. "Borderline" epithelial lesions of the breast: what have we learned in the past three decades?